AtriCure, Inc. Operating Lease Cost
AtriCure, Inc. (ATRC) reported Operating Lease Cost of $471.00 thousand for the 3-month period ending 2026-06-30, per its 10-Q filed 2026-07-27.
Financial Statements › Expense Statement › Operating Expenses
us-gaap:OperatingLeaseCost · last filed 2026-07-27
- AtriCure, Inc. operating lease, cost for the quarter ending 2026-06-30 was $471.00K, a 4.07% decline year-over-year.
- AtriCure, Inc. operating lease, cost for the quarter ending 2026-03-31 was $530.00K, a 13.73% increase year-over-year.
- AtriCure, Inc. operating lease, cost for the quarter ending 2025-12-31 was $520.00K, a 21.78% increase year-over-year.
- AtriCure, Inc. operating lease, cost for the quarter ending 2025-09-30 was $504.00K, a 19.15% increase year-over-year.
- AtriCure, Inc. operating lease, cost for fiscal 2025 was $1.98M, a 22.74% increase from fiscal 2024.
- AtriCure, Inc. operating lease, cost for fiscal 2024 was $1.61M, a 25.70% increase from fiscal 2023.
- AtriCure, Inc. operating lease, cost for fiscal 2023 was $1.28M, a 13.33% increase from fiscal 2022.
- AtriCure, Inc. operating lease, cost for fiscal 2022 was $1.13M, a 7.70% increase from fiscal 2021.
| Period end | Operating Lease, Cost 3 month | Operating Lease, Cost 6 month | Operating Lease, Cost 9 month | Operating Lease, Cost 12 month |
|---|---|---|---|---|
| 2026-06-30 | $471.00K 10-Q · filed 2026-07-27 | $1.00M 10-Q · filed 2026-07-27 | $1.52M derived: sum of 3 quarters · filed 2026-07-27 | $2.02M derived: sum of 4 quarters · filed 2026-07-27 |
| 2026-03-31 | $530.00K 10-Q · filed 2026-05-06 | $1.05M derived: sum of 2 quarters · filed 2026-05-06 | $1.55M derived: sum of 3 quarters · filed 2026-05-06 | $2.04M derived: sum of 4 quarters · filed 2026-07-27 |
| 2025-12-31 | $520.00K derived: 10-K 12 month − 10-Q 9 month · filed 2026-02-19 | $1.02M derived: sum of 2 quarters · filed 2026-02-19 | $1.51M derived: sum of 3 quarters · filed 2026-07-27 | $1.98M 10-K · filed 2026-02-19 |
| 2025-09-30 | $504.00K 10-Q · filed 2025-10-30 | $995.00K derived: sum of 2 quarters · filed 2026-07-27 | $1.46M 10-Q · filed 2025-10-30 | $1.89M derived: sum of 4 quarters · filed 2026-07-27 |
| 2025-06-30 | $491.00K 10-Q · filed 2026-07-27 | $957.00K 10-Q · filed 2026-07-27 | $1.38M derived: sum of 3 quarters · filed 2026-07-27 | $1.81M derived: sum of 4 quarters · filed 2026-07-27 |
| 2025-03-31 | $466.00K 10-Q · filed 2026-05-06 | $893.00K derived: sum of 2 quarters · filed 2026-05-06 | $1.32M derived: sum of 3 quarters · filed 2026-05-06 | $1.70M derived: sum of 4 quarters · filed 2026-05-06 |
| 2024-12-31 | $427.00K derived: 10-K 12 month − 10-Q 9 month · filed 2026-02-19 | $850.00K derived: sum of 2 quarters · filed 2026-02-19 | $1.23M derived: sum of 3 quarters · filed 2026-02-19 | $1.61M 10-K · filed 2026-02-19 |
| 2024-09-30 | $423.00K 10-Q · filed 2025-10-30 | $807.00K derived: sum of 2 quarters · filed 2025-10-30 | $1.19M 10-Q · filed 2025-10-30 | $1.51M derived: sum of 4 quarters · filed 2026-02-19 |
| 2024-06-30 | $384.00K 10-Q · filed 2025-07-30 | $764.00K 10-Q · filed 2025-07-30 | $1.09M derived: sum of 3 quarters · filed 2026-02-19 | $1.41M derived: sum of 4 quarters · filed 2026-02-19 |
| 2024-03-31 | $380.00K 10-Q · filed 2025-04-30 | $704.00K derived: sum of 2 quarters · filed 2026-02-19 | $1.03M derived: sum of 3 quarters · filed 2026-02-19 | $1.35M derived: sum of 4 quarters · filed 2026-02-19 |
| 2023-12-31 | $324.00K derived: 10-K 12 month − 10-Q 9 month · filed 2026-02-19 | $649.00K derived: sum of 2 quarters · filed 2026-02-19 | $974.00K derived: sum of 3 quarters · filed 2026-02-19 | $1.28M 10-K · filed 2026-02-19 |
| 2023-09-30 | $325.00K 10-Q · filed 2024-10-30 | $650.00K derived: sum of 2 quarters · filed 2024-10-30 | $960.00K 10-Q · filed 2024-10-30 | $1.24M derived: sum of 4 quarters · filed 2025-02-14 |
| 2023-06-30 | $325.00K 10-Q · filed 2024-07-31 | $635.00K 10-Q · filed 2024-07-31 | $917.00K derived: sum of 3 quarters · filed 2025-02-14 | $1.20M derived: sum of 4 quarters · filed 2025-02-14 |
| 2023-03-31 | $310.00K 10-Q · filed 2024-05-02 | $592.00K derived: sum of 2 quarters · filed 2025-02-14 | $873.00K derived: sum of 3 quarters · filed 2025-02-14 | $1.16M derived: sum of 4 quarters · filed 2025-02-14 |
| 2022-12-31 | $282.00K derived: 10-K 12 month − 10-Q 9 month · filed 2025-02-14 | $563.00K derived: sum of 2 quarters · filed 2025-02-14 | $847.00K derived: sum of 3 quarters · filed 2025-02-14 | $1.13M 10-K · filed 2025-02-14 |
| 2022-09-30 | $281.00K 10-Q · filed 2023-11-02 | $565.00K derived: sum of 2 quarters · filed 2023-11-02 | $851.00K 10-Q · filed 2023-11-02 | $1.19M derived: sum of 4 quarters · filed 2024-02-16 |
| 2022-06-30 | $284.00K 10-Q · filed 2023-07-26 | $570.00K 10-Q · filed 2023-07-26 | $907.00K derived: sum of 3 quarters · filed 2024-02-16 | $1.14M derived: sum of 4 quarters · filed 2024-02-16 |
| 2022-03-31 | $286.00K 10-Q · filed 2023-05-03 | $623.00K derived: sum of 2 quarters · filed 2024-02-16 | $857.00K derived: sum of 3 quarters · filed 2024-02-16 | $1.06M derived: sum of 4 quarters · filed 2024-02-16 |
| 2021-12-31 | $337.00K derived: 10-K 12 month − 10-Q 9 month · filed 2024-02-16 | $571.00K derived: sum of 2 quarters · filed 2024-02-16 | $774.00K derived: sum of 3 quarters · filed 2024-02-16 | $1.05M 10-K · filed 2024-02-16 |
| 2021-09-30 | $234.00K 10-Q · filed 2022-11-02 | $437.00K derived: sum of 2 quarters · filed 2022-11-02 | $715.00K 10-Q · filed 2022-11-02 | $967.00K derived: sum of 4 quarters · filed 2023-02-22 |
| 2021-06-30 | $203.00K 10-Q · filed 2022-08-03 | $481.00K 10-Q · filed 2022-08-03 | $733.00K derived: sum of 3 quarters · filed 2023-02-22 | $1.03M derived: sum of 4 quarters · filed 2023-02-22 |
| 2021-03-31 | $279.00K 10-Q · filed 2022-05-04 | $530.00K derived: sum of 2 quarters · filed 2023-02-22 | $823.00K derived: sum of 3 quarters · filed 2023-02-22 | $1.16M derived: sum of 4 quarters · filed 2023-02-22 |
| 2020-12-31 | $251.00K derived: 10-K 12 month − 10-Q 9 month · filed 2023-02-22 | $544.00K derived: sum of 2 quarters · filed 2023-02-22 | $884.00K derived: sum of 3 quarters · filed 2023-02-22 | $1.24M 10-K · filed 2023-02-22 |
| 2020-09-30 | $293.00K 10-Q · filed 2021-11-04 | $633.00K derived: sum of 2 quarters · filed 2021-11-04 | $986.00K 10-Q · filed 2021-11-04 | $1.33M derived: sum of 4 quarters · filed 2022-02-17 |
| 2020-06-30 | $340.00K 10-Q · filed 2021-08-05 | $690.00K 10-Q · filed 2021-08-05 | $1.04M derived: sum of 3 quarters · filed 2022-02-17 | $1.33M derived: sum of 4 quarters · filed 2022-02-17 |
| 2020-03-31 | $349.00K 10-Q · filed 2021-04-28 | $701.00K derived: sum of 2 quarters · filed 2022-02-17 | $986.00K derived: sum of 3 quarters · filed 2022-02-17 | $1.15M derived: sum of 4 quarters · filed 2022-02-17 |
| 2019-12-31 | $352.00K derived: 10-K 12 month − 10-Q 9 month · filed 2022-02-17 | $637.00K derived: sum of 2 quarters · filed 2022-02-17 | $796.00K derived: sum of 3 quarters · filed 2022-02-17 | $952.00K 10-K · filed 2022-02-17 |
| 2019-09-30 | $285.00K 10-Q · filed 2020-11-06 | $444.00K derived: sum of 2 quarters · filed 2020-11-06 | $600.00K 10-Q · filed 2020-11-06 | |
| 2019-06-30 | $159.00K 10-Q · filed 2020-07-29 | $318.00K 10-Q · filed 2020-07-29 | ||
| 2019-03-31 | $159.00K 10-Q · filed 2020-04-30 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| iRhythm Holdings, Inc. (IRTC) | United States | $3.651B | -281.06 |
| PULSE BIOSCIENCES, INC. (PLSE) | United States | $3.696B | -24.47 |
| UFP TECHNOLOGIES INC (UFPT) | United States | $2.308B | 28.37 |
| ICU MEDICAL INC/DE (ICUI) | United States | $4.153B | 18.85 |
| Inspire Medical Systems, Inc. (INSP) | United States | $1.990B | 9.55 |
| Heartflow, Inc. (HTFL) | United States | $4.225B | |
| NovoCure Ltd (NVCR) | $1.886B | -11.87 | |
| LEMAITRE VASCULAR INC (LMAT) | United States | $1.848B | 33.37 |
| KESTRA MEDICAL TECHNOLOGIES, LTD. (KMTS) | United States | $1.535B | -9.02 |
| Alphatec Holdings, Inc. (ATEC) | United States | $1.531B | -12.14 |